Avastin's commercial march suffers setback


879 Wilson says. The committee was looking for evidence that the patients were either living longer or that there were “meaningful” clinical improvements that offset the drug’s side effects. They found neither. “I hope physicians will take heed of the committee’s decision and do not continue prescribing the drug,” Wilson adds. The FDA usually follows ODAC… (More)
DOI: 10.1038/nbt0910-879


1 Figure or Table